The correlation between risk scores and the clinical stage of UCEC
To further investigate the practicality of DALPMs, we examined their use in forecasting risks in various clinical phases. The results from the KM curve showed a notable variation in survival rates among patients with varying risk scores in clinical stages I-II and III-IV (Fig. 